首页|联合用药治疗老年性高血压78例临床疗效分析

联合用药治疗老年性高血压78例临床疗效分析

扫码查看
高血压本身不是一种严重的疾病,但它引起的重要脏器的并发症己对人类构成严重的威胁。我国近20年来随着经济的发展,人们的饮食结构和生活习惯发生了很大的变化,不良的生活方式加速了老年性高血压的发展;本文阐述络活喜和安博维联用治疗老年性中度高血压,降压作用明显增加,能逆转左室肥厚,且持久温和,血压波动小,能减少蛋白尿,改善肾功能,而且不良反应减少,减少心血管病终点事件发生率,患者依从性好,适用于老年性高血压。
hypertension itself is not a serious illness, but it raises important organ complications has been a serious threat to human. China in recent 20 years, with the development of economy, people's diet and living habits have undergone great changes, the bad way of life accelerated aging hypertension development; this paper describes Norvasc and Abovi combined therapy on elderly patients with moderate hypertension, antihypertensive action to increase apparently, can reverse left ventricular hypertrophy, and persistent mild, blood pressure fluctuation is small, can reduce urinary protein, improve renal function, and reduce the adverse reaction, reduce cardiovascular disease endpoints event rate, patient compliance is good, suitable for senile hypertension.

senile hypertensionNorvascBoRenitec

赵莉萍

展开 >

黑龙江省大庆油田总医院集团乘风医院急诊科 163411

老年性高血压 络活喜 安博 悦宁定

2013

中国保健营养(中旬刊)
全国卫生产业企业管理协会

中国保健营养(中旬刊)

ISSN:1004-7484
年,卷(期):2013.(1)
  • 1